Overcoming antibody barriers to transplantation: ABO-incompatible and positive cross-match kidney transplantation at Mayo Clinic - Rochester

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Over the past several years, protocols have been developed to allow patients with antibody against either donor blood group (ABO-incompatible) or donor HLA antigens (positive cross-match) to undergo successful kidney transplantation. Important factors determining the development of hyperacute rejection, humoral rejection and long-term graft survival have been defined. In this review, the clinical experience with ABO-incompatible and positive cross-match kidney transplantation at Mayo Clinic, Rochester are described with an emphasis on both patient management issues and gaps in our current knowledge in this emerging field.

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalInternational Congress Series
Volume1292
DOIs
StatePublished - Jul 2006

    Fingerprint

Keywords

  • Donor-specific alloantibody
  • DSA
  • Living donor kidney transplantation (LDKTx)

ASJC Scopus subject areas

  • Medicine(all)

Cite this